Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients

Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Therefore, we initiated a clinical phase I CMVpp65 p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sommerer, Claudia (VerfasserIn) , Schmitt, Anita (VerfasserIn) , Hückelhoven-Krauss, Angela (VerfasserIn) , Giese, Thomas (VerfasserIn) , Bruckner, Thomas (VerfasserIn) , Wang, Lei (VerfasserIn) , Schnitzler, Paul (VerfasserIn) , Meuer, Stefan (VerfasserIn) , Zeier, Martin (VerfasserIn) , Schmitt, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 February 2021
In: Vaccines
Year: 2021, Jahrgang: 9, Heft: 2, Pages: 1-15
ISSN:2076-393X
DOI:10.3390/vaccines9020133
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/vaccines9020133
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2076-393X/9/2/133
Volltext
Verfasserangaben:Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier and Michael Schmitt

MARC

LEADER 00000caa a2200000 c 4500
001 1753142679
003 DE-627
005 20230426165440.0
007 cr uuu---uuuuu
008 210406s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/vaccines9020133  |2 doi 
035 |a (DE-627)1753142679 
035 |a (DE-599)KXP1753142679 
035 |a (OCoLC)1341403406 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sommerer, Claudia  |d 1971-  |e VerfasserIn  |0 (DE-588)121857654  |0 (DE-627)705680002  |0 (DE-576)292921829  |4 aut 
245 1 0 |a Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients  |c Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier and Michael Schmitt 
264 1 |c 6 February 2021 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.09.2021 
520 |a Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Therefore, we initiated a clinical phase I CMVpp65 peptide vaccination trial for seronegative end-stage renal disease patients waiting for kidney transplantation. Methods: The highly immunogenic nonamer peptide NLVPMVATV derived from CMV phosphoprotein 65(CMVpp65) in a water-in-oil emulsion (Montanide™) plus imiquimod (Aldara™) as an adjuvant was administered subcutaneously four times biweekly. Clinical course as well as immunological responses were monitored using IFN-γ ELISpot assays and flow cytometry for CMV-specific CD8+ T cells. Results: Peptide vaccination was well tolerated, and no drug-related serious adverse events were detected except for Grade I-II local skin reactions. Five of the 10 patients (50%) mounted any immune response (responders) and 40% of the patients presented CMV-specific CD8+ T cell responses elicited by these prophylactic vaccinations. No responders experienced CMV reactivation in the 18 months post-transplantation, while all non-responders reactivated. Conclusion: CMVpp65 peptide vaccination was safe, well tolerated, and clinically encouraging in seronegative end-stage renal disease patients waiting for kidney transplantation. Further studies with larger patient cohorts are planned. 
650 4 |a CMV reactivation 
650 4 |a cytomegalovirus (CMV) 
650 4 |a phosphoprotein 65 (pp65) peptide vaccination 
650 4 |a renal transplantation 
650 4 |a specific T cells 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Hückelhoven-Krauss, Angela  |d 1983-  |e VerfasserIn  |0 (DE-588)1034095889  |0 (DE-627)744057280  |0 (DE-576)381742822  |4 aut 
700 1 |a Giese, Thomas  |d 1962-  |e VerfasserIn  |0 (DE-588)143133543  |0 (DE-627)704399075  |0 (DE-576)333724496  |4 aut 
700 1 |a Bruckner, Thomas  |d 1956-  |e VerfasserIn  |0 (DE-588)136046215  |0 (DE-627)574429298  |0 (DE-576)300798768  |4 aut 
700 1 |a Wang, Lei  |d 1985-  |e VerfasserIn  |0 (DE-588)1076031994  |0 (DE-627)834093308  |0 (DE-576)444802398  |4 aut 
700 1 |a Schnitzler, Paul  |d 1959-  |e VerfasserIn  |0 (DE-588)1022905643  |0 (DE-627)717329798  |0 (DE-576)366155695  |4 aut 
700 1 |a Meuer, Stefan  |d 1951-  |e VerfasserIn  |0 (DE-588)1020440198  |0 (DE-627)691221286  |0 (DE-576)360422454  |4 aut 
700 1 |a Zeier, Martin  |e VerfasserIn  |0 (DE-588)1026480302  |0 (DE-627)726772356  |0 (DE-576)371826438  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
773 0 8 |i Enthalten in  |t Vaccines  |d Basel : MDPI, 2013  |g 9(2021), 2, Artikel-ID 133, Seite 1-15  |h Online-Ressource  |w (DE-627)736559205  |w (DE-600)2703319-3  |w (DE-576)37898585X  |x 2076-393X  |7 nnas  |a Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients 
773 1 8 |g volume:9  |g year:2021  |g number:2  |g elocationid:133  |g pages:1-15  |g extent:15  |a Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients 
856 4 0 |u https://doi.org/10.3390/vaccines9020133  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2076-393X/9/2/133  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210406 
993 |a Article 
994 |a 2021 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 10  |y j 
998 |g 1026480302  |a Zeier, Martin  |m 1026480302:Zeier, Martin  |d 910000  |d 910100  |d 50000  |e 910000PZ1026480302  |e 910100PZ1026480302  |e 50000PZ1026480302  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 9 
998 |g 1020440198  |a Meuer, Stefan  |m 1020440198:Meuer, Stefan  |d 910000  |d 911600  |e 910000PM1020440198  |e 911600PM1020440198  |k 0/910000/  |k 1/910000/911600/  |p 8 
998 |g 1022905643  |a Schnitzler, Paul  |m 1022905643:Schnitzler, Paul  |d 910000  |d 911700  |d 50000  |e 910000PS1022905643  |e 911700PS1022905643  |e 50000PS1022905643  |k 0/910000/  |k 1/910000/911700/  |k 0/50000/  |p 7 
998 |g 1076031994  |a Wang, Lei  |m 1076031994:Wang, Lei  |p 6 
998 |g 136046215  |a Bruckner, Thomas  |m 136046215:Bruckner, Thomas  |d 910000  |d 999701  |e 910000PB136046215  |e 999701PB136046215  |k 0/910000/  |k 1/910000/999701/  |p 5 
998 |g 143133543  |a Giese, Thomas  |m 143133543:Giese, Thomas  |d 910000  |d 911600  |d 50000  |e 910000PG143133543  |e 911600PG143133543  |e 50000PG143133543  |k 0/910000/  |k 1/910000/911600/  |k 0/50000/  |p 4 
998 |g 1034095889  |a Hückelhoven-Krauss, Angela  |m 1034095889:Hückelhoven-Krauss, Angela  |d 910000  |d 910100  |e 910000PH1034095889  |e 910100PH1034095889  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2 
998 |g 121857654  |a Sommerer, Claudia  |m 121857654:Sommerer, Claudia  |d 50000  |e 50000PS121857654  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1753142679  |e 3902074027 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1753142679"],"doi":["10.3390/vaccines9020133"]},"name":{"displayForm":["Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier and Michael Schmitt"]},"note":["Gesehen am 09.09.2021"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients","title_sort":"Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patients"}],"relHost":[{"origin":[{"dateIssuedDisp":"2013-","dateIssuedKey":"2013","publisherPlace":"Basel","publisher":"MDPI"}],"pubHistory":["1.2013 -"],"id":{"zdb":["2703319-3"],"eki":["736559205"],"issn":["2076-393X"]},"part":{"extent":"15","text":"9(2021), 2, Artikel-ID 133, Seite 1-15","issue":"2","pages":"1-15","volume":"9","year":"2021"},"title":[{"title":"Vaccines","title_sort":"Vaccines","subtitle":"open access journal"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 14.02.13"],"recId":"736559205","physDesc":[{"extent":"Online-Ressource"}],"disp":"Peptide vaccination against cytomegalovirus induces specific T cell response in responses in CMV seronegative end-stage renal disease patientsVaccines"}],"person":[{"family":"Sommerer","given":"Claudia","role":"aut","display":"Sommerer, Claudia"},{"display":"Schmitt, Anita","role":"aut","given":"Anita","family":"Schmitt"},{"display":"Hückelhoven-Krauss, Angela","role":"aut","given":"Angela","family":"Hückelhoven-Krauss"},{"role":"aut","given":"Thomas","family":"Giese","display":"Giese, Thomas"},{"family":"Bruckner","given":"Thomas","role":"aut","display":"Bruckner, Thomas"},{"family":"Wang","role":"aut","given":"Lei","display":"Wang, Lei"},{"family":"Schnitzler","role":"aut","given":"Paul","display":"Schnitzler, Paul"},{"display":"Meuer, Stefan","role":"aut","given":"Stefan","family":"Meuer"},{"display":"Zeier, Martin","family":"Zeier","role":"aut","given":"Martin"},{"family":"Schmitt","role":"aut","given":"Michael","display":"Schmitt, Michael"}],"origin":[{"dateIssuedDisp":"6 February 2021","dateIssuedKey":"2021"}],"physDesc":[{"extent":"15 S."}],"recId":"1753142679"} 
SRT |a SOMMERERCLPEPTIDEVAC6202